Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Quang Kim Tran

Quang Kim Tran

Associate Professor
Des Moines University
USA

Biography

Quang Kim Tran received an MD from the University of Medicine and Pharmacy at Ho Chi Minh City, Vietnam and a PhD in Vascular Biology and Clinical Cardiology Fellowship from Hamamatsu University School of Medicine, Japan. He pursued Post-doctoral Training in the School of Biological Sciences, University of Missouri–Kansas City, USA, where he later became a Research Instructor. He is now an Associate Professor in the Department of Physiology and Pharmacology, Des Moines University College of Osteopathic Medicine, Iowa, USA. He has served as President of the Iowa Chapter of the American Physiological Society and as Reviewer for various scientific journals in the cardiovascular field. involves understanding causes for type 2 diabetes and potential therapeutic targets. The main aim of the team is to develop translational multidisciplinary medical research into obesity and type 2 diabetes. The current research programmes are exploring the underlying mechanisms that lead to the pathogenesis of obesity mediated type 2 diabetes. As such we have researchers within the team focussed on human metabolism examining several aspects such as: the importance of adipokines on human adipocyte signalling, mediators and mechanisms of inflammation, understanding the importance of diet and cell signalling in response to metabolic endotoxinaemia, the role of ectopic fat in the liver and heart, as well as using mathematical modelling of human adipocyte systems.

Research Interest

Novel mechanistic insights into the actions of the G-protein coupled estrogen receptor as a moderator of cardiovascular health.A mechanistic model for the role of GPER as a moderator of cardiovascular functions will be presented. The data and summative model encourage therapeutic exploitation of GPER activation and expression in the management of cardiovascular morbidity.